New Mexicomed spa & injectable regulations
What’s changing for med spas and injectors in New Mexico — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in New Mexico. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Latest New Mexico changes
No New Mexico-specific changes have crossed our radar yet — we’re actively monitoring the New Mexico legislature and licensing boards. The federal changes below apply to every New Mexico practice today.
Federal changes that apply in New Mexico
FDA and Federal Register actions are nationwide — they govern New Mexico practices too.
- CRITICALFEDERALFDA Enforcement2025-09-10
FDA recall (Class II): Semaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn Pharmacy
FDA recalls compounded GLP-1 product for being subpotent.
- CRITICALFEDERALFDA Enforcement2025-08-13
FDA recall (Class II): Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri…
FDA recalls compounded GLP-1 product; check your stock now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880…
FDA recalls Wegovy; med spas must check supplies!
- CRITICALFEDERALFDA Enforcement2026-03-11
FDA recall (Class II): Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061,…
FDA recalls Semaglutide for sterility issues—act now!
- CRITICALFEDERALFDA Enforcement2026-01-07
FDA recall (Class II): Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 B…
FDA recalls Wegovy due to safety concerns; med spas must act.
- CRITICALFEDERALFDA Enforcement2025-07-02
FDA recall (Class II): Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80…
FDA recalls GLP-1 product over sterility issues.
What we monitor in New Mexico
- New Mexico legislature — bills on injectables, GLP-1s & scope of practice
- New Mexico Board of Nursing — injector scope & delegation
- New Mexico Medical Board — physician supervision & ownership rules
- New Mexico Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
New Mexico med spa compliance — FAQ
- Where do New Mexico med spa and injectable regulations come from?
- New Mexico med spas and injectors are governed by a mix of state and federal authorities — the New Mexico legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for New Mexico and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in New Mexico?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in New Mexico. We track those federal changes alongside any New Mexico-specific rules so you see the full picture for your practice.
- How do I keep up with New Mexico regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across New Mexico, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Never miss a New Mexico change
Get the free weekly Brief on what changed across New Mexico, the FDA, and the Federal Register. Members get the exact what-to-do, in real time, for their states.
Get the free Brief →← All states · Regulatory monitoring, not legal advice.